Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence

BACKGROUND: The behavioural impact of pharmacogenomics is untested; informing smokers of genetic test results for responsiveness to smoking cessation medication may increase adherence to this medication. The objective of this trial is to estimate the impact upon adherence to nicotine replacement the...

Descripción completa

Detalles Bibliográficos
Autores principales: Marteau, Theresa M, Munafò, Marcus R, Aveyard, Paul, Hill, Chloe, Whitwell, Sophia, Willis, Thomas A, Crockett, Rachel A, Hollands, Gareth J, Johnstone, Elaine C, Wright, Alison J, Prevost, A Toby, Armstrong, David, Sutton, Stephen, Kinmonth, Ann Louise
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996370/
https://www.ncbi.nlm.nih.gov/pubmed/21062464
http://dx.doi.org/10.1186/1471-2458-10-680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996370/
https://www.ncbi.nlm.nih.gov/pubmed/21062464
http://dx.doi.org/10.1186/1471-2458-10-680

Ejemplares similares